Zim Laboratories Ltd

Mon 9/11/2026,16:0:20 | NSE : ZIMLAB

₹136.862.34 (1.74%)

Data is delayed. Analysis is best done in real-time! Open a FREE Sharekhan Demat A/c in 15 mins* and continue your analysis with real-time data.

Market Data

Essential tool: analyze, trade, manage, decide.

Open

₹ 137.40

Previous Close

₹ 134.52

Volume

46083

Mkt Cap ( ₹ Cr)

₹ 734.37

High

₹ 138.00

Low

₹ 132.00

52 Week High

₹ 159.81

52 Week Low

₹ 59.31

Book Value Per Share

₹ 54.47

Dividend Yield

0.00

Face Value

₹ 10.00

What's Your Call?

Collective community sentiment on Zim Laboratories Ltd

Your Vote -

Buy

40.00%

Hold

0.00%

Sell

60.00%

40.00%

5 users have voted

Market Depth

How many stocks are available to buy or sell and at what prices.

Buy Order Quantity

NaN%

Sell Order Quantity

NaN%

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Bid Price

Qty

0.00

0

0.00

0

0.00

0

0.00

0

0.00

0

Bid Total

0

Option Chain

Analyzes market sentiment, predicts Zim Laboratories Ltd' movement.

NO_RECORD_FOUND

News

Media spotlight triggers stock stock attention, sentiment.

  • Zim Laboratories - Analysts/Institutional Investor Meet/Con. Call Updates

    5 Nov 2026, 4:07PM Zim Laboratories Limited has informed the Exchange about Link of Recording

  • Zim Laboratories - Copy of Newspaper Publication

    5 Nov 2026, 12:16PM Zim Laboratories Limited has informed the Exchange about Copy of Newspaper Publication for financial results for the quarter and half year ended 30.09

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Outcome

    5 Nov 2026, 4:16PM Please find enclosed the disclosure pertaining to the audio recording of Q2 & H1 FY27 Earnings Conference Call.

  • Zim Laboratories - Please Find Enclosed Earnings Presentation For Q2 & H1 FY27

    4 Nov 2026, 8:41PM Pursuant to Regulation 30 of SEBI (LODR) Regulations, 2015, please find enclosed the Earnings Presentation for Q2 & H1 FY27.

  • Zim Laboratories - General Updates

    4 Nov 2026, 8:34PM Zim Laboratories Limited has informed the Exchange about General Updates

  • Zim Laboratories - Outcome of Board Meeting

    4 Nov 2026, 2:36PM Zim Laboratories Limited has submitted to the Exchange, the financial results for the period ended September 30, 2026.

  • Zim Laboratories posts Q2 net loss of Rs 2.14 cr

    4 Nov 2026, 3:30PM The company reported standalone net loss during the quarter stood at Rs 2.14 crore compared to net profit of Rs 0.12 crore in the previous year quarte

  • Zim Laboratories - Results - Financial Results For The Quarter And Half Year Ended 30Th September 2026

    4 Nov 2026, 2:49PM Please find enclosed the financial results for the quarter and half year ended 30th September 2026

  • Zim Laboratories - Board Meeting Outcome for Outcome Of The Board Meeting

    4 Nov 2026, 2:43PM Pursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we would like to inform you that the Board of D

  • Zim Laboratories - Analysts/Institutional Investor Meet/Con. Call Updates

    31 Oct 2026, 2:13PM Zim Laboratories Limited has informed the Exchange about Schedule of meet

  • Zim Laboratories - Analysts/Institutional Investor Meet/Con. Call Updates

    31 Oct 2026, 2:02PM Zim Laboratories Limited has informed the Exchange about Schedule of meet

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Analyst / Investor Meet - Intimation

    31 Oct 2026, 2:15PM We wish to inform you that Q2 & H1FY27 Earnings Conference Call is scheduled to be held on Thursday, 05th November, 2026 at 11:00 a.m. IST.

  • Zim Laboratories - Board Meeting Intimation for Consideration And Approval Of The Unaudited Financial Results (Standalone And

    28 Oct 2026, 4:13PM Zim Laboratories Ltdhas informed BSE that the meeting of the Board of Directors of the Company is scheduled on 04/11/2026 ,inter alia, to consider and

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Press Release / Media Release

    16 Oct 2026, 12:54PM Please find enclosed the Press Release relating to grant of GMP Certification of Compliance by Australia's TGA to the Company for its manufacturing fa

  • Zim Laboratories - Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals

    16 Oct 2026, 12:51PM Zim Laboratories Limited has informed the Exchange about Granting/withdrawal/surrender/cancellation/suspension of key licenses/ regulatory approvals

  • Zim Laboratories has submitted to BSE the Shareholding Pattern for the Period Ended September 30, 2026

    12 Oct 2026, 5:50PM As of September 2026, 30.30% is owned by Indian Promoters and 69.70% by Public. <p align=justify> Top five Promoters holding highest number of shares

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Credit Rating

    8 Oct 2026, 8:20PM Please find enclosed the disclosure under Regulation 30 of SEBI (LODR) Regulations 2015 regarding Credit Rating

  • Zim Laboratories - Credit Rating

    8 Oct 2026, 8:18PM Zim Laboratories Limited has informed the Exchange about Credit Rating

  • Zim Laboratories - Certificate under SEBI (Depositories and Participants) Regulations, 2018

    8 Oct 2026, 6:15PM Zim Laboratories Limited has informed the Exchange about Certificate under SEBI (Depositories and Participants) Regulations, 2018

  • Zim Laboratories - Compliances-Certificate under Reg. 74 (5) of SEBI (DP) Regulations, 2018

    8 Oct 2026, 6:06PM Certificate under Regulation 74(5) of SEBI(DP) Regulations 2018 for the quarter ended 30th September,2026 is enclosed herewith .

  • Zim Laboratories - Trading Window

    28 Sep 2026, 12:24PM Zim Laboratories Limited has informed the Exchange regarding the Trading Window closure pursuant to SEBI (Prohibition of Insider Trading) Regulations,

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Updates on Acquisition

    18 Sep 2026, 8:12AM Intimation for incorporation of wholly owned subsidiary

  • Zim Laboratories - General Updates

    18 Sep 2026, 8:10AM Zim Laboratories Limited has informed the Exchange about General Updates

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Updates on Acquisition

    15 Sep 2026, 7:51PM Update on completion of investment in the share capitalof ZIM Scientific Office L.L.C. (Step Down Subsidiary) by ZIM Laboratories Limited FZE, wholly

  • Zim Laboratories - General Updates

    15 Sep 2026, 7:42PM Zim Laboratories Limited has informed the Exchange about General Updates

  • Zim Laboratories posts Q1 net loss of Rs 3.88 cr

    19 Aug 2026, 8:20PM The company reported standalone net loss during the quarter stood at Rs 3.88 crore as compared to net loss of Rs 1.69 crore in the previous year quart

  • Zim Laboratories - Analysts/Institutional Investor Meet/Con. Call Updates

    12 Aug 2026, 7:22PM Zim Laboratories Limited has informed the Exchange about Transcript

  • Zim Laboratories - Announcement under Regulation 30 (LODR)-Earnings Call Transcript

    12 Aug 2026, 7:21PM Transcript of Q1 FY27 Earning Conference call

  • Zim Laboratories - Shareholders meeting

    12 Aug 2026, 5:23PM Zim Laboratories Limited has submitted the Exchange a copy Srutinizers report of Postal Ballot. Further, the company has informed the Exchange regard

  • Zim Laboratories - Shareholder Meeting / Postal Ballot-Scrutinizer\s Report

    12 Aug 2026, 5:28PM Please find enclosed the Scrutinizer's Report and Voting Results of Postal Ballot.

  • Zim Laboratories - Shareholder Meeting / Postal Ballot-Outcome of Postal_Ballot

    12 Aug 2026, 5:25PM Please find enclosed the Outcome of Postal Ballot .
Load More
Show Less

Key fundamentals

Evaluate the intrinsic value of Zim Laboratories Ltd stock 

Name March-26 March-25 March-24 March-23 March-22
Assets 409.336 356.6793 338.3068 253.7463 221.2899
Liabilities 409.336 356.6793 338.3068 253.7463 221.2899
Equity 53.5003 48.7258 48.7258 48.7258 16.2419
Gross Profit 29.58 43.2684 40.1024 51.1911 37.934
Net Profit 5.9652 11.744 16.7555 25.0088 13.0128
Cash From Operating Activities 47.6584 50.602 11.472 35.2318 47.0265
NPM(%) 1.61 3.12 4.58 6.3 3.94
Revenue 370.4815 375.6355 365.4732 396.5313 329.4937
Expenses 340.9015 332.3671 325.3708 345.3402 291.5597
ROE(%) 2.04 4.01 5.73 8.55 4.45

Shareholding Pattern

Corporate Action

XD-Date Dividend-Amount Dividend-% Dividend Yield(%GE) Price on that day

Peers

Other companies within the same industry or sector that are comparable to Zim Laboratories Ltd

Company Price Price (% change) pe(x) EV/EBITDA(x) ROE(%) ROCE(%)
Albert David Ltd 800.90 0.89 20.26 78.50 -26.19 0.62
Lotus Eye Hospital and Institute Ltd 99.53 -4.29 1421.86 286.05 0.39 0.00
Vaishali Pharma Ltd 7.02 1.15 21.94 1794.50 15.42 0.00
Astec Lifesciences Ltd 527.20 -7.07 0.00 306.49 -363.14 0.00

Company Info

The company was incorporates in the state of Maharashtra on 14th February, 1984, under the name and style of Zim Laboratories Ltd. The promoters of the company were Shri Z S Vali, Shri M M Kamal, and Shri I A Trivedi. The company is engaged in manufacturing pharmaceutical product in the form of tablets, capsules and syrups. The company became a Public Ltd. Company by passing special resolution dated 25th January 1992 and fresh certificate of incorporation was obtained from Registrar of Companies, Maharashtra Bombay, on 21st January, 1993. The company commenced commercial production on 7th December 1989 and there was no delay in implementation of the project. 2018 -The Company has issued Bonus Shares in the Ratio of 1:1. 2022 -The Company has issued Bonus Shares in the Ratio of 2:1. -Company received Global Nagpur Awards - December 2022. 2023 -Company Received Excellence In Pharma Global Business - April 2023. 2025-ZIM Laboratories Limited and Globalpharma Co. (L.L.C.) Announced Strategic Collaboration to Commercialize Oral Thin Film Products in the GCC Region.

The company was incorporates in the state of Maharashtra on 14th February, 1984, under the name and style of Zim Laboratories Ltd. The promoters of the company were Shri Z S Vali, Shri M M Kamal, and Shri I A Trivedi. The company is engaged in manufacturing pharmaceutical product in the form of tablets, capsules and syrups. The company became a Public Ltd. Company by passing special resolution dated 25th January 1992 and fresh certificate of incorporation was obtained from Registrar of Companies, Maharashtra Bombay, on 21st January, 1993. The company commenced commercial production on 7th December 1989 and there was no delay in implementation of the project. 2018 -The Company has issued Bonus Shares in the Ratio of 1:1. 2022 -The Company has issued Bonus Shares in the Ratio of 2:1. -Company received Global Nagpur Awards - December 2022. 2023 -Company Received Excellence In Pharma Global Business - April 2023. 2025-ZIM Laboratories Limited and Globalpharma Co. (L.L.C.) Announced Strategic Collaboration to Commercialize Oral Thin Film Products in the GCC Region.

Parent Organisation

Zim Laboratories Ltd.

Founded

14/02/1984

Managing Director

Dr.Anwar Daud

NSE Symbol

ZIMLABEQ

FAQ